These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34113617)

  • 21. Epigenetic Marks in Polycystic Ovary Syndrome.
    Motta AB
    Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic/circadian clocks and PCOS.
    Vatier C; Christin-Maitre S
    Hum Reprod; 2024 Jun; 39(6):1167-1175. PubMed ID: 38600622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.
    Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
    Fertil Steril; 2015 Jul; 104(1):145-53.e6. PubMed ID: 25956362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
    Cui P; Ma T; Tamadon A; Han S; Li B; Chen Z; An X; Shao LR; Wang Y; Feng Y
    Exp Physiol; 2018 Dec; 103(12):1618-1632. PubMed ID: 30204276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome.
    He T; Liu Y; Zhao S; Liu H; Wang Z; Shi Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():134-140. PubMed ID: 30594023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic Ovary Syndrome: Novel and Hub lncRNAs in the Insulin Resistance-Associated lncRNA-mRNA Network.
    Zhao J; Huang J; Geng X; Chu W; Li S; Chen ZJ; Du Y
    Front Genet; 2019; 10():772. PubMed ID: 31507635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of genomic DNA methylation in PCOS pathogenesis: a systematic review and meta-analysis involving case-controlled clinical studies.
    Rawat K; Sandhu A; Gautam V; Saha PK; Saha L
    Mol Hum Reprod; 2022 Jul; 28(8):. PubMed ID: 35789386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.
    Wang P; Zhao H; Li T; Zhang W; Wu K; Li M; Bian Y; Liu H; Ning Y; Li G; Chen ZJ
    Endocrinology; 2014 Apr; 155(4):1445-52. PubMed ID: 24527662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epigenetics of polycystic ovary syndrome].
    Concha C F; Sir P T; Recabarren SE; Pérez B F
    Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
    Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
    Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINE1 CpG-DNA Hypomethylation in Granulosa Cells and Blood Leukocytes Is Associated With PCOS and Related Traits.
    Sagvekar P; Mangoli V; Desai S; Patil A; Mukherjee S
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1396-1405. PubMed ID: 28324041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic research in PCOS: are we reaching new frontiers?
    Ben-Shlomo I; Younis JS
    Reprod Biomed Online; 2014 Jun; 28(6):669-83. PubMed ID: 24768413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
    Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
    Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
    Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and potential value of candidate microRNAs in granulosa cells of polycystic ovary syndrome.
    Wang Y; Xu S; Wang Y; Qi G; Hou Y; Sun C; Wu X
    Technol Health Care; 2019; 27(6):579-587. PubMed ID: 30932905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine Reprogramming of the Polycystic Ovary Syndrome: Evidence from a Pilot Study of Cord Blood Global Methylation Analysis.
    Lambertini L; Saul SR; Copperman AB; Hammerstad SS; Yi Z; Zhang W; Tomer Y; Kase N
    Front Endocrinol (Lausanne); 2017; 8():352. PubMed ID: 29326659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients.
    Li X; Zhu Q; Wang W; Qi J; He Y; Wang Y; Lu Y; Wu H; Ding Y; Sun Y
    FASEB J; 2019 Oct; 33(10):11303-11313. PubMed ID: 31311314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.